
Anuh Pharma Share Price
₹163.00 +1.95 (1.21%)
22 Feb, 2025 21:38
Start SIP in
ANUHPHR
Performance
- Low
- ₹160
- High
- ₹166
- 52 Week Low
- ₹158
- 52 Week High
- ₹246
- Open Price₹164
- Previous Close₹161
- Volume19,187
Investment Returns
- Over 1 Month -19.88%
- Over 3 Month -13.96%
- Over 6 Month -23.51%
- Over 1 Year -28.05%
Smart Investing Starts Here Start SIP with Anuh Pharma for Steady Growth!
Anuh Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16.3
- PEG Ratio
- -2.2
- Market Cap Cr
- 817
- P/B Ratio
- 2.7
- Average True Range
- 7.74
- EPS
- 10.03
- Dividend Yield
- 1.5
- MACD Signal
- -9.57
- RSI
- 26.77
- MFI
- 23.2
Anuh Pharma Financials
Anuh Pharma Technicals
EMA & SMA
Current Price
₹163.00
+
1.95
(1.21%)
-
- Bearish Moving Average 0
-
- Bullish Moving Average 0
- 20 Day
- ₹180.32
- 50 Day
- ₹194.02
- 100 Day
- ₹201.24
- 200 Day
- ₹202.30
Resistance and Support
163.43
- R3 168.02
- R2 166.58
- R1 164.87
- S1 161.72
- S2 160.28
- S3 158.57
Anuh Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-07 | Quarterly Results & Others | To consider other business matters. per share(55%)Interim Dividend |
2024-11-08 | Quarterly Results | |
2024-08-09 | Quarterly Results | |
2024-05-17 | Audited Results & Final Dividend | |
2024-02-09 | Quarterly Results |
Anuh Pharma F&O
About Anuh Pharma
- NSE Symbol
- ANUHPHR
- BSE Symbol
- 506260
- Joint Managing Director
- Mr. Ritesh B Shah
- ISIN
- INE489G01022
Similar Stocks to Anuh Pharma
Anuh Pharma FAQs
Anuh Pharma share price is ₹163 As on 22 February, 2025 | 21:24
The Market Cap of Anuh Pharma is ₹816.8 Cr As on 22 February, 2025 | 21:24
The P/E ratio of Anuh Pharma is 16.3 As on 22 February, 2025 | 21:24
The PB ratio of Anuh Pharma is 2.7 As on 22 February, 2025 | 21:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.